Elon Musk is under examination as reports surfaced regarding his alleged drug use, causing concerns among top executives and board members of the companies he leads. The Wall Street Journal, citing unnamed sources, disclosed that Elon Musk has reportedly used substances such as LSD, cocaine, ecstasy, and psychedelic mushrooms, often in private party settings where guests are required to sign non-disclosure agreements and surrender their phones.
The Wall Street Journal report, published on January 8, 2024, made claims that Musk has used LSD, cocaine, ecstasy, psychedelic mushrooms, and ketamine at private parties.
Witnesses, including unnamed sources, alleged that Musk’s drug use has been ongoing, with specific concerns about his consumption of ketamine, which he claimed to use as an antidepressant with a prescription.
Musk took to the social media platform X, which he owns, to address the allegations. Musk denied the reports, stating that not even trace amounts of drugs or alcohol were found in his system during three years of random drug testing, initiated at NASA’s request after an incident on Joe Rogan’s podcast in 2018.
Musk’s lawyer, Alex Spiro, also refuted the Wall Street Journal’s report, labeling it as containing false facts. The controversy surrounding Musk’s drug use gained public attention in 2018 when he smoked marijuana during an episode of the Joe Rogan Experience podcast.
This incident made the Pentagon to review Musk’s federal security clearance, as SpaceX, one of Musk’s companies, holds certifications for launching military spy satellites.
Musk clarified that he had only taken one puff during the podcast and agreed to three years of random drug testing at NASA’s request.
The Wall Street Journal’s report goes into Musk’s alleged drug use at private parties, claiming that he has taken various substances, including LSD and magic mushrooms.
The report suggests that executives from Tesla and SpaceX have expressed concerns about the impact of Musk’s reported drug use on the companies and his overall behavior.
While Musk has publicly admitted to using ketamine, a drug prescribed for depression, he contends that it is done under prescription and as a treatment.
The Wall Street Journal’s report also touches on Musk’s use of ketamine at a party in 2021, an event attended by his brother Kimbal Musk and SpaceX board member Steve Jurvetson.
The report says, a meeting in 2017 at SpaceX headquarters, where Musk’s speech was described as “nonsensical,” “unhinged,” and “cringeworthy.”
While it remains unclear if Musk was intoxicated during the meeting, executives privately questioned whether drugs played a role in his behavior.
Additionally, some Tesla board members, including chair Robyn Denholm, reportedly approached Musk’s brother, Kimbal, seeking help with Musk’s behavior without mentioning drugs.
Elon Musk is currently the wealthiest person globally, with a net worth estimated at $243.5 billion, primarily based on his ownership stakes in Tesla and SpaceX.
The Wall Street Journal’s report concerns about the impact of Musk’s reported drug use on the companies’ stability and the value of his assets, which are estimated to be worth around $1 trillion.
Any form of illegal drug use could violate corporate regulations at both SpaceX and Tesla, jeopardizing federal contracts worth billions of dollars, especially for SpaceX.
The report also suggested that Tesla board members, including the current chair Robyn Denholm, expressed concerns about Musk’s behavior, with some approaching Musk’s brother, Kimbal Musk, for assistance without mentioning drugs.
The departure of former Tesla director Linda Johnson Rice in 2019 was linked to concerns over Musk’s behavior and drug consumption.